About PharmaGap (CVE:GAP)
PharmaGap Inc. (PharmaGap) is a development-stage company. The Company is principally engaged in drug development and out-licensing of drug compounds. The Company is focused on the development of novel drugs for treatment of cancer and other human disease conditions. PharmaGap's lead drug compound, GAP-107B8, is in the pre-clinical testing stage and has shown in vitro and in vivo efficacy in selected cancer types. During the year ended December 31, 2011, the Company commenced specific programs to further elucidate information regarding the pharmacokinetics and toxicity profiles of GAP-107B8. A program to develop liposomal delivery formulations of GAP-107B8 in order to optimize the delivery and safety of the drug compound was completed during 2011. The Company is developing GAP-107B8 for first clinical trials in ovarian cancer, using the intra-peritoneal route of administration.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
PharmaGap (CVE:GAP) Frequently Asked Questions
What is PharmaGap's stock symbol?
PharmaGap trades on the Canadian Venture Exchange (CVE) under the ticker symbol "GAP."
Who are some of PharmaGap's key competitors?
Some companies that are related to PharmaGap include Painted Pony Energy (PPY), Pure Industrial Real Estate Trust (AAR.UN), Pure Multi Family Reit Lp Cad (RUF.UN), Intertain Group (AQT.P), Organigram (OGI), Kaminak Gold (KAM), Roxgold (ROG), Pure Multi-Family REIT (RUF.U), Cobalt 27 Capital (KBLT), Lumina Copper (LCC), People (PEO), Leucrotta Exploration (LXE), Falcon Oil & Gas (FO), Blackbird Energy (BBI), Atlantic Gold (AGB), Luna Gold (LGC), Blackline Safety (BLN) and Victoria Gold (VIT).
How do I buy PharmaGap stock?
Shares of PharmaGap and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
How can I contact PharmaGap?
PharmaGap's mailing address is 1000 Innovation Drive, Suite 400, OTTAWA, ON K2K 2K7, Canada. The company can be reached via phone at +1-613-2873118.
MarketBeat Community Rating for PharmaGap (GAP)MarketBeat's community ratings are surveys of what our community members think about PharmaGap and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
PharmaGap (CVE:GAP) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Earnings History for PharmaGap (CVE:GAP)
No earnings announcements for this company have been tracked by MarketBeat.com
PharmaGap (CVE:GAP) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for PharmaGap (CVE:GAP)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for PharmaGap (CVE GAP)
No insider trades for this company have been tracked by MarketBeat.com
PharmaGap (CVE GAP) News Headlines
No headlines for this company have been tracked by MarketBeat.com
PharmaGap (CVE:GAP) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
PharmaGap (CVE GAP) Stock Chart for Sunday, February, 25, 2018